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Background: The study was designed to provide account of etiological agents of urinary tract infection in pediatric 
patients and the antimicrobial resistance pattern plus biofilm producing profile of the isolates.
Methods: The prospective study was conducted in Alka Hospital, Nepal with 353 clean catch urine samples from 
children. It was obtained during July 2014 to January 2015 which were first cultured by semi-quantitative method, 
followed by antimicrobial susceptibility testing and biofilm production assay on Congo red agar. Multidrug- resistance, 
extensively drug- resistance and pandrug- resistance among isolates were considered as per international consensus.
Results:  Out of 353 samples, 64 (18.13%) showed positive growth in culture, confirming urinary tract infection. 
E. coli, 44 (68.8%) was the predominant organism followed by Klebsiella spp. 6 (14.1%). Most E. coli were sensitive to 
amikacin (93.2%) followed by nitrofurantoin (86.4%), and highly resistant to ampicillin (95.5%). Of 64 isolates, 23 
(35.93%) were found to be multidrug- resistant strains. Biofilm was produced by 36 (56.25%) isolates.
Conclusions: This study showed higher biofilm production and resistance to in-use antibiotics rendering ineffective 
for empirical use. Regular surveillance of resistance patterns should be done to regulate multidrug- resistant bugs and 
to ensure effective management of urinary tract infection in children in a tertiary care setups.
Keywords:  AMR; antimicrobial resistance; biofilm; urinary tract infection; UTI.
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INTRODUCTION
Urinary tract infection (UTI), an infection of urethra, 
bladder, ureters and/or kidney, has significant morbidity 
and mortality.1,2Outpatient morbidity of UTI in Nepal 
was 311,944.3 UTIs affect at least 3.6% of boys and 
11% of girls.4 UTI can lead to terminal renal disease in 
children.5 Epidemiological reports point Escherichia coli 
as the most common cause of UTI in children.6,7
Biofilm, which account 80% of infections, is a sessile 
cells embedded in extracellular matrix.8,9 The matrix 
assist in exhibiting an altered phenotype e.g. increased 
antimicrobial resistance (AMR).10 Biofilm thus boosts 
pathogenicity of uropathogenic E. coli (UPEC).11
AMR, i.e. resistance against previously effective 
antibiotics, is the global threats to human health.12,13 
AMR increases morbidity, mortality, health-care cost 
and hospitalization.14 Antibiotic choice should be based 
on AMR profiles of local strains varying temporally and 
geographically.15UTI in children is treated empirically 
to avoid complications.16 Biofilm associated AMR has 
burthen the management of UTI. The study was done to 
insight uropathogens in pediatric UTI patients along with 
their AMR pattern and biofilm producing profile.
METHODS
The prospective study was conducted in the department 
of Microbiology of Alka Hospital, Lalitpur, Nepal; a 
tertiary level hospital. A total of 353 clean catch urine 
samples from children under 13 years of age were 
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2015).
Urine culture was performed on routine culture media 
by semi-quantitative method as described in World 
Health Organization (WHO) manual.17 Briefly, 1μL of 
urine was inoculated on MacConkey and blood agar plate 
by streaking using calibrated loop (2mm), and incubated 
aerobically for 18-48 hrs at 37ᵒC. Growth of 100 colonies 
or more, i.e. 105 colony forming units (CFU)/mL urine, 
was considered as positive growth. Isolation and 
identification of microorganisms were done by standard 
microbiological operation procedure as described in the 
Manual of Clinical Microbiology.18
Antimicrobial susceptibility testing of all isolates against 
in-use antibiotics was performed by Kirby-Bauer disc 
diffusion method and interpretation of the results was 
done as described by Clinical and Laboratory Standard 
Institute (CLSI) 2013.19 Antibiotic discs used were 
amikacin (30μg), ampicillin (10μg), cefepime (30μg), 
cefoxitin (30μg), cephalexin (30μg), ciprofloxacin (5μg), 
cotrimoxazole (1.25/23.75μg), gentamicin (10μg), 
imipenem (10μg), nitrofurantoin (300μg), norfloxacin 
(10μg), ofloxacin (5μg), piperacillin (100μg), and 
vancomycin (30μg). Organisms resistant to three or more 
classes of antibiotics were considered to be multidrug 
resistance (MDR). Similarly, extensively drug- resistance 
(XDR) and pandrug- resistance (PDR) organisms were 
considered as per international consensus.20
Detection of biofilm producers among isolates was done 
by culturing on Congo red agar. Intensity of color change 
of Congo red agar on microbial growth is proportional to 
the biofilm production by the organisms. Considering the 
intensity of color change, organisms were categorizedas 
strong biofilm producers, moderate biofilm producers, 
weak biofilm producers and biofilm non producers.
Ethical approval was obtained from Ethical Review 
Board, Nepal Health Research Council (NHRC), Nepal 
(Reg. no. 147/2014). Written informed consent was 
obtained from the guardian of children before enrolling 
to the study.
RESULTS
A total of 353 clean catch urine samples from children, 
under 13 years of age, were included under the study. 
The median age of children was 4 years (Interquartile 
range=5 years) with boys to girls ratio of 1:1.37. Samples 
from 64(18.13%) children showed positive growth in 
culture with boys to girls ratio of 1:1.21. UTI was more 
frequent in Indo-Aryan race compared to that in Sino-
Tibetan race with ratio of 1.9:1 (Table 1).
Table 1. Distribution of patients. 
Total children UTI confirmed children
Types of patients
Out patients 282 55




Age distribution (Median age =4 years, Interquartile 
range =5 years)
<3 months 33 13
3 months-3 years 129 27




Total children 353 64
Ten different bacterial genera were isolated. E. coli, 
44 (68.8%) was the predominant isolate followed by 
Klebsiella spp., 6 (14.1%) (Table 2).
Table 2. Pattern of bacterial isolates. 
Gram’s type of 
bacteria






C. freundii 1 (1.6)
Enterobacter spp. 1 (1.6)
E. coli 44 (68.8)
Klebsiella spp. 6 (9.4)
M. morganii 2 (3.1)
Proteus spp. 3 (4.7)
Providencia spp. 3 (4.7)
P. aeruginosa 1 (1.6)
Gram-positive 
bacteria S. aureus 2 (3.1)
Total 64 (100)
In E. coli isolates, resistivity was highest to ampicillin 
(95.5%) and least to amikacin (6.8%). In other Gram-
negative isolates, resistivity was highest to cefepime 
(33.3%) and least to amikacin (11.1%), gentamicin 
(11.1%), and piperacillin (11.1%) (Table 3).
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Of 64 isolates, 23 (35.93%) were MDR. All 23 MDR strains 
were E. coli isolates. Biofilm production in all isolates 
was higher i.e. 36 (56.25%) (Table 4).
Higher rate of antimicrobial resistance was found in 
biofilm producing E. coli strains. (Table 5)






















Non MDR 21 1 3 2 15
MDR 23 8 6 3 6
XDR 9 5 3 0 1
Possible XDR 11 2 3 1 5
PDR 0 0 0 0 0
Possible PDR 1 1 0 0 0
DISCUSSION
Increasing AMR among common isolates is posing 
difficulty in the management of UTI in pediatrics. Our 
study revealed high AMR and biofilm production among 
uropathogens. In our study, bacterial growths of ≥105 
CFU/mL in culture were considered as positive growth 
and thus UTI.17 Only 64 (18.13%) samples showed positive 
growth. This signifies the need for review of in-use general 
microbiological methods and clinical examination. 
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Table 3. Antibiotic resistivity profile of isolates. 
Class of antibiotics Antibiotics E. coli (n=44)* Other Gram-negative isolates (n=18)* S. aureus (n=2)
*
Aminoglycosides
Amikacin 6.8% 11.1% NT
Gentamicin 36.4% 11.1% 0%
Beta lactam Piperacillin NT 11.1% NT
Carbapenems Imipenem NT 0% NT
Cephalosporins I Cephalexin 44.2% NT NT
Cephalosporins II Cefoxitin NT NT 100%
Cephalosporins IV Cefepime NT 33.3% NT
Fluoroquinolones
Ciprofloxacin 40.9% 27.8% 0%
Ofloxacin 38.6% 22.2% NT
Norfloxacin NT NT 0%
Glycopeptides Vancomycin NT NT 0%
Nitrofurans Nitrofurantoin 13.6% NT 0%
Penicillins Ampicillin 95.5% NT 100%
Sulphonamide Co-trimoxazole 61.4% 27.8% 0%
NT= Not tested, *Percentage calculated on n
Table 4. MDR profile and biofilm production among isolates. 
Bacteria isolated
Biofilm production
MDR isolates Total isolatesStrong producer Moderate producer Weak producer Non producer
Acinetobacter spp. 0 0 1 0 0 1
C. freundii 0 0 0 1 0 1
Enterobacter spp. 0 1 0 0 0 1
E. coli 9 9 5 21 23 44
Klebsiella spp. 2 1 1 2 0 6
M. morganii 0 0 1 1 0 2
Proteus spp. 0 0 2 1 0 3
Providencia spp. 0 1 0 2 0 3
P. aeruginosa 0 1 0 0 0 1
S. aureus 0 0 2 0 0 2
Total 11 13 12 28 23 64
JNHRC Vol. 16 No. 2 Issue 39 Apr - Jun 2018 181
Biofilm Production and Antimicrobial Resistance among Uropathogens in Pediatric Cases
Prior antibiotic treatment before submitting the urine 
sample, and other UTI like clinical conditions could be 
the factors responsible for low growth positivity.
In our study, the ratio of outpatients to inpatients was 
3.97:1, while that in UTI confirmed children was 6.11:1. 
This implies higher prevalence of UTI in community 
children. In our study, boys to girls ratio was 1:1.21 in 
UTI confirmed children. UTI is more prevalent in girls, 
the natural epidemiology pattern.21 Girls are more 
frequently affected by UTI due to colonizing colonic 
Gram-negative bacteria in urethra because of its anal 
proximity and shorter length.22 Higher UTI prevalence in 
girls was also reported by other studies.2,6 UTI was more 
frequent in Indo-Aryan race children compared to Sino-
Tibetan race children with ratio of 1.9:1.
Gram-negative bacteria were predominant isolates 62 
(96.88%) compared to 2 (3.12%) Gram-positive bacteria.
Enterobacteriaceae family comprised of 54 (84.38%) 
bacteria. E. coli was the most predominant isolate 44 
(68.75%), followed by Klebsiella spp. 6 (9.38%). This 
concords with reports from other studies.6,7,15,21,23 UTI 
onsets when E. coli or other enterobacteria accesses 
and ascends the urethra. These organisms are among 
gastrointestinal tract flora colonizing periurethral area.24
The evolution of resistance against antibiotics is not a 
new phenomenon. And there is continual increase in 
reporting of AMR in recent years. In this study, E. coli, 
principal pathogen isolated, showed high resistivity to 
ampicillin (95.5%) and least to amikacin (6.8%). This 
concord with other studies.6,7,15,21,23Likewise, imipenem 
and amikacin were found most effective against 
other Gram-negative isolates and cefepime the least. 
Moreover, ciprofloxacin, co-trimoxazole, gentamicin 
and nitrofurantoin were found most effective for Gram-
positive isolates. Development of MDR strains among 
common isolates of health care associated infection has 
been a major concern due to development of MDR strains 
among common isolates. Only 23 (35.93%) isolates were 
found MDR. This was similar to the other study.2
Co-trimoxazole, commonly used to treat pediatric UTI 
orally, was effective only against one third of isolates. 
Nitrofurans can still be relied upon as 1st line choice, 
the economical option too. But, higher resistance 
against fluoroquinolones renders it ineffective for 2nd 
line treatment. One of the most important findings in 
this study is the resistance to cephalexin with resistance 
rate of 44.2% for E. coli which portrays lower generation 
cephalosporins as unreliable empiric antibiotics. 
Empiric use of amikacin until the sensitivity pattern is 
available might be a reasonable choice. For avoiding 
complications, most children are treated empirically 
with antibiotics even before culture and susceptibility 
reports arrives.21 Resistance against antibiotics is 
increasing nowadays in community patients. Also, lack 
of access to health facilities and  inadequate public 
awareness are added worries.25 In recent years, AMR 
is rising, self-medication being one but not the only 
reason.26 Furthermore, antibiotic resistance is the 
holistic effect of inappropriate antibiotic policies, poor 
surveillance plus compliance, easy access to antibiotics, 
self-medication of antibiotics with poor adherence, 
suboptimal dosing, diagnostic errors, counterfeit drug of 
low quality, uncontrolled antibiotics use in agriculture 
and indiscriminate use of antibiotics without proper 
diagnosis or identification of causative agent.25,27,28
Biofilm production was higher in the isolates i.e. 36 
(56.25%). In this study, biofilm production was found 
associated with high MDR, XDR and possible PDR. The 
biofilm stage determines the level of resistance. In 
initial phase, antibiotics and host immune system are 
the most effective.10 Once the bacteria begin to secrete 
EPS and the attachment becomes irreversible, biofilm 
resist more against antibiotics and host immunity.10 In 
addition, the spread of resistance markers and virulence 
factors can be promoted.29 Combination therapy 
with macrolides (erythromycin, clarithromycin, and 
azithromycin) is recommended for biofilm-associated 
infections by different studies. Macrolides inhibits 
alginate thus averts matrix formation fort biofilm.30
Asia is regarded as one of the epicenters of AMR.31 
Inappropriate antibiotics treatment is the common 
healthcare practice, making this region the high risk area 
for AMR evolution. Our study highlights a high rate of MDR 
among uropathogens and a broad range of uropathogens 
in this setting. Variability of antibiotic resistance pattern 
as per different regions and recent continuous increase 
in resistant strains to new antibiotics has posed great 
difficulty in selecting appropriate antimicrobial agents 
for management of infection they caused. Also leading 
to increase in cost with need of new costly drugs as 
wells as prolonged hospital stay. Since, the study was 
limited to single tertiary setting, broader surveillance is 
must to disseminate local resistance profile of prevalent 
uropathogens. This will ensure the optimal empirical 
therapy of UTI. And macrolides should be supplement 
along with other antibiotic therapy to circumvent 
evolution of resistance by biofilm production. The 
small sample size from single tertiary setting outlines 
the limitation of the findings to generalize in the larger 
population. Also phenotypic characterization cannot be 
solely relied upon to describe the inherent cause of the 
AMR in population.
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CONCLUSIONS
Majority of uropathogens causing UTI in pediatrics 
were Gram-negative bacteria with predominance of E. 
coli in a tertiary care setup. Amikacin and gentamicin 
were found effective against most of the Gram-
negative bacterial isolates, including E. coli. One-
third of the isolates were found to be MDR. The study 
demonstrates high resistance to commonly prescribed 
antibiotics. Thus, testing of antimicrobial susceptibility 
of uropathogens is preeminent before starting antibiotic 
therapy. Majority of the isolates were biofilm producers 
rendering higher antimicrobial resistance. Macrolides 
can be supplemented along with antibiotics.
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